Provided by Tiger Trade Technology Pte. Ltd.

West Pharmaceutical

271.86
+4.301.61%
Post-market: 271.860.00000.00%19:35 EST
Volume:692.71K
Turnover:187.54M
Market Cap:19.56B
PE:40.27
High:272.80
Open:267.97
Low:265.97
Close:267.56
52wk High:348.90
52wk Low:187.43
Shares:71.94M
Float Shares:71.41M
Volume Ratio:1.02
T/O Rate:0.97%
Dividend:0.84
Dividend Rate:0.31%
EPS(TTM):6.75
EPS(LYR):6.75
ROE:16.94%
ROA:10.22%
PB:6.41
PE(LYR):40.28

Loading ...

West Pharma Is Maintained at Outperform by Evercore ISI Group

Dow Jones
·
Oct 24

BUZZ-U.S. STOCKS ON THE MOVE-LendingClub, Hasbro, Intel

Reuters
·
Oct 24

Evercore ISI Adjusts West Pharmaceutical Services PT to $390 From $350, Maintains Outperform Rating

MT Newswires Live
·
Oct 24

BUZZ-U.S. STOCKS ON THE MOVE-Lam Research, Rivian Automotive, Eli Lilly

Reuters
·
Oct 24

Early notable gainers among liquid option names on October 23rd

TIPRANKS
·
Oct 23

Stock Track | West Pharmaceutical Soars 9.41% on Strong Q3 Results and Raised 2025 Outlook

Stock Track
·
Oct 23

BUZZ-U.S. STOCKS ON THE MOVE-Blackstone, Darling Ingredients, Harmony Biosciences

Reuters
·
Oct 23

West Pharmaceutical Services Reports Strong Q3 2025 Results

TIPRANKS
·
Oct 23

BUZZ-U.S. STOCKS ON THE MOVE-Ventyx Biosciences, Dow, Las Vegas

Reuters
·
Oct 23

West Pharmaceutical Shares Rise 6.6% Premarket After Co Lifts Annual Profit Forecast

THOMSON REUTERS
·
Oct 23

Stock Track | West Pharmaceutical Soars 6.50% Pre-market on Strong Q3 Results and Raised 2025 Guidance

Stock Track
·
Oct 23

West Pharma boosts annual profit forecast on strong demand for its drug components

Reuters
·
Oct 23

West Pharmaceutical ups FY25 adjusted EPS view to $7.06-$7.11 from $6.65-$6.85

TIPRANKS
·
Oct 23

West Pharmaceutical Servs Q3 Adj. EPS $1.96 Beats $1.68 Estimate, Sales $804.600M Beat $787.929M Estimate

Benzinga
·
Oct 23

West Pharmaceutical Services Inc Q4 Shr View $1.78, REV View $796.2 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
Oct 23

West Pharmaceutical Services: Q4 2025 Financial Guidance Reported Net Sales Growth Anticipated to Be in Range of 5.5% to 6.8%

THOMSON REUTERS
·
Oct 23

West Pharmaceutical Services Inc: Expects Fourth-Quarter 2025 Adjusted-Diluted EPS Guidance Range of $1.81 to $1.86

THOMSON REUTERS
·
Oct 23

West Pharmaceutical Services Inc: Expects Fourth-Quarter 2025 Net Sales Guidance Range of $790 Mln to $800 Mln

THOMSON REUTERS
·
Oct 23

Corrected-West Pharmaceutical: FY Adj EPS Guidance Range Raised From $6.65 to $6.85 Earlier (Not ‘FY EPS USD 6.65-6.85’)

THOMSON REUTERS
·
Oct 23

West Pharmaceutical Outlook FY Adjusted EPS USD 7.06-7.11

THOMSON REUTERS
·
Oct 23